Literature DB >> 3743593

Conservative surgery of renal cell carcinoma.

M A Bazeed, T Schärfe, E Becht, C Jurincic, P Alken, J W Thüroff.   

Abstract

From 1967 to 1985 conservative surgery (enucleation, n = 49; partial resection, n = 7) was performed for renal tumors in 57 patients (age 31-77, mean 54.8 years). Imperative indications for conservative surgery (n = 29) were chronic renal failure, benign pathology of contralateral kidney, functional or anatomical solitary kidney, and bilateral tumors. Elective conservative surgery (n = 28) was done for small, peripherally located lesions, in cases of uncertain malignancy and in one tumor detected by chance during stone surgery. Tumors removed for imperative indications were 2-11 cm (mean 5.8 cm) in size. In the elective group, tumor size ranged from 1 to 7 cm (mean 3.3 cm). Follow-up was 6-103 months (mean 35.8 months). In the group with imperative indications, there was 1 postoperative mortality; 18 of 29 patients are alive without evidence of disease, 2 with metastases, and 2 were reoperated conservatively for local recurrences; 1 was lost to follow-up, 2 died of metastases, and 3 died due to unrelated reasons. In the elective group all 28 patients are living free of cancer.

Entities:  

Mesh:

Year:  1986        PMID: 3743593     DOI: 10.1159/000472627

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  12 in total

Review 1.  Should there be a size limit for elective nephron-sparing surgery?

Authors:  Kent G Krejci; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

Review 2.  [Minimally invasive vs. open surgical procedures in the treatment of renal cell carcinoma].

Authors:  J W Thüroff; F Roos
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

3.  Differential diagnosis of histogenetically distinct human epithelial renal tumours with a monoclonal antibody against gamma-glutamyltransferase.

Authors:  P Fischer; S Störkel; W Haase; J E Scherberich
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Nephron-sparing surgery for renal cell carcinoma.

Authors:  K H Tsui; A van Ophoven; O Shvarts; A Belldegrun
Journal:  Rev Urol       Date:  1999

5.  Multicentricity in renal cell carcinoma.

Authors:  C Y Bilen; K Mahalati; H Ozen; F T Aki; C Ilyas; S Kendi
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 6.  Factors influencing adrenal metastasis in renal cell carcinoma.

Authors:  S M Moudouni; I En-nia; A Manunta; F Guillé; B Lobel
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

7.  Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferase.

Authors:  P Fischer; R P Baum; M Tauber; W Boeckmann; S Weier; J E Scherberich
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  Nephron sparing surgery for renal cell carcinoma in a solitary kidney.

Authors:  Sascha Pahernik; Frederik Roos; Chistoph Wiesner; Joachim W Thüroff
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

Review 9.  [Imperative nephron-sparing surgery for cases of solitary kidney/bilateral tumors: long-term results].

Authors:  F C Roos; S Pahernik; A Elsässer; A Victor; W Brenner; J W Thüroff
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

10.  CT after enucleation of renal cell carcinoma.

Authors:  H U Kauczor; S Schadmand-Fischer; D Filipas; H C Schwickert; F Steinbach; H H Schild; M Thelen
Journal:  Abdom Imaging       Date:  1994 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.